Mark Roskey
Chief Tech/Sci/R&D Officer bij QUANTERIX CORPORATION
Vermogen: 460 415 $ op 29-02-2024
Profiel
Mark T.
Roskey is Chief Science & Collaboration Officer at Quanterix Corp.
Dr. Roskey previously occupied the position of Senior VP-Applied Biology Research & Development at Caliper Life Sciences, Inc. and Vice President-Worldwide Marketing at Zymark Corp.
(a subsidiary of Caliper Life Sciences, Inc.), Vice President & GM-LST Americas Sales & Services at Revvity, Inc. and Marketing Director of Applied Biosystems, Inc.
Dr. Roskey received an undergraduate degree from Framingham State College and a doctorate from the University of Notre Dame.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
QUANTERIX CORPORATION
0.05% | 01-03-2023 | 19 216 ( 0.05% ) | 460 415 $ | 29-02-2024 |
Actieve functies van Mark Roskey
Bedrijven | Functie | Begin |
---|---|---|
QUANTERIX CORPORATION | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Mark Roskey
Bedrijven | Functie | Einde |
---|---|---|
REVVITY, INC. | Corporate Officer/Principal | 01-09-2014 |
Zymark Corp.
Zymark Corp. Medical SpecialtiesHealth Technology Zymark is a provider of laboratory automation, liquid handling and robotics solutions to the life sciences, biotechnology and pharmaceutical industries. | Sales & Marketing | 01-08-2003 |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Sales & Marketing | - |
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Mark Roskey
University of Notre Dame | Doctorate Degree |
Framingham State College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
REVVITY, INC. | Health Technology |
QUANTERIX CORPORATION | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Electronic Technology |
Zymark Corp.
Zymark Corp. Medical SpecialtiesHealth Technology Zymark is a provider of laboratory automation, liquid handling and robotics solutions to the life sciences, biotechnology and pharmaceutical industries. | Health Technology |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |